Language Select
Logotipo da Varian

Press Releases

Setembro 20, 2018
The phrase "You have cancer" understandably strikes fear into the hearts of millions of patients diagnosed with the disease every year around the world. But what if we lived in a world without the... Read more
Setembro 12, 2018
Varian (NYSE: VAR) today announced that Jeffrey R. Balser, MD, PhD, president and chief executive officer at Vanderbilt University Medical Center and dean of Vanderbilt University School of... Read more
Setembro 07, 2018
Varian (NYSE: VAR) signed a partnership agreement with Mediheal Group of Hospitals to expand access to radiotherapy in Kenya. This comprehensive partnership agreement includes the supply of... Read more
Setembro 04, 2018
Varian (NYSE: VAR) today announced the installation of the cyclotron for the Varian ProBeam® Compact single-room proton therapy system at the cancer treatment center on the campus of the Delray... Read more
Agosto 23, 2018
Varian (NYSE: VAR) today announced that Gary Bischoping, chief financial officer, and J. Michael Bruff, senior vice president of investor relations, will present at the Baird Global Healthcare... Read more
Agosto 22, 2018
Varian (NYSE: VAR) today announced its fourth quarter fiscal year 2018 earnings release date and upcoming investor meeting at the American Society for Radiation Oncology (ASTRO) Annual Meeting.... Read more
Agosto 21, 2018
Varian's (NYSE: VAR) president and chief executive officer, Dow R. Wilson, has joined the Board of Directors of the US-India Strategic Partnership Forum (USISPF). Mr. Wilson is among a group of... Read more
Agosto 06, 2018
Varian (NYSE: VAR) today announced the acquisition of privately-held humediQ Global GmbH, the manufacturer of IDENTIFY, an automated patient identification, positioning and motion management... Read more
Julho 25, 2018
Varian (NYSE: VAR) today announced its third quarter fiscal year 2018 results. All comparisons in this announcement are year-over-year unless noted otherwise. Summary (Dollars and shares in... Read more
Julho 24, 2018
Varian (NYSE: VAR) today announced it will be showcasing its advanced cancer care solutions including a new version of Eclipse™ treatment planning software with support for Halcyon™ 2.0... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
[email protected]

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
[email protected]

Monica Prokocki
Director, Investor Relations
650.424.5184
[email protected]